Inactive/Delisted stock
TC Biopharm Stock (NASDAQ:TCBP)
Previous Close
$1.95
52W Range
$1.70 - $523.20
50D Avg
$5.75
200D Avg
$66.41
Market Cap
$274.00
Avg Vol (3M)
$280.62K
Beta
0.01
Div Yield
-
TCBP Company Profile
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.